Skip to main content

Day: March 11, 2024

Spirit Blockchain Capital and Troon Technologies Announce Collaboration with Alvara on ERC-7621 Token Standard Development

Please click to view image Vancouver, British Columbia, March 11, 2024 (GLOBE NEWSWIRE) — In a collaborative effort, Spirit Blockchain Capital (CSE: SPIR), together with its subsidiary Troon Technologies, has partnered with software development firm Alvara to further the development of the ERC-7621 Token Standard, a new initiative aimed at enhancing blockchain-based fund management for institutional clients. This partnership marks a strategic move towards the integration of innovative blockchain solutions within the financial sector. The ERC-7621 Token Standard is designed to facilitate the creation of on-chain, multi-asset tokenized baskets, offering a new framework for managing investment portfolios. By enabling the deployment of Basket Tokens, which can hold a variety of underlying ERC-20 tokens, the standard seeks to introduce...

Continue reading

WAVE Charging Appoints Macy Neshati as General Manager to Spearhead Expansion and Scale

Salt Lake, Utah, March 11, 2024 (GLOBE NEWSWIRE) — WAVE Charging, a wholly-owned subsidiary of Ideanomics (NASDAQ: IDEX) and developer of high-power, wireless inductive charging solutions for medium- and heavy-duty commercial vehicles, proudly announces the appointment of Macy Neshati as General Manager.   In his new role, Neshati will take charge of overseeing operations and driving the expansion of WAVE Charging’s current customer base, including the two confidential commercial fleet customers previously disclosed.   Mr. Neshati brings a wealth of experience to his new position, including experience as part of the Ideanomics group of companies. Prior to joining WAVE Charging, he served as the CEO of Ideanomics subsidiary U.S. Hybrid. During his tenure, he played a pivotal role in enhancing and expanding U.S. Hybrid’s...

Continue reading

Lexeo Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights

Lexeo announces $95.0M equity financing, which in addition to 2023 year-end cash and cash equivalents of $121.5M, extends runway to fund operations into 2027 Reports frataxin protein expression data from a subset of the second dose cohort of SUNRISE-FA, a Phase 1/2 clinical trial of LX2006 for the treatment of Friedreich’s ataxia (FA) cardiomyopathy, showing positive change in post-treatment frataxin levels Additional interim data readout from SUNRISE-FA expected in mid-2024, with follow-up out to one year from the low-dose and multiple time points of follow-up expected from at least three patients treated at the mid-dose Initiated SNAPSHOT-PKP2, a natural history study designed to evaluate PKP2-ACM disease progression up to two years retrospectively and over twelve months prospectively, in up to 20 patients in the U.S. All milestones...

Continue reading

Smart Share Global Limited Declares a Special Cash Dividend

SHANGHAI, China, March 11, 2024 (GLOBE NEWSWIRE) — Smart Share Global Limited (Nasdaq: EM) (“Energy Monster” or the “Company”), a consumer tech company providing mobile device charging service, today announced that its Board of Directors approved a special cash dividend of US$0.015 per ordinary share, or US$0.03 per American Depositary Share (“ADS”), to holders of ordinary shares and holders of ADSs of record as of the close of business on May 31, 2024, U.S. Eastern Time, payable in U.S. dollars. Dividend to be paid to the Company’s ADS holders through the depositary bank will be subject to the terms of the deposit agreement. The payment date is expected to be on or around June 7, 2024 for holders of ordinary shares and on or around June 14, 2024 for holders of ADSs. The total amount of cash to be distributed for the dividend is...

Continue reading

Genie Energy Announces Fourth Quarter and Full Year 2023 Results

Record Fourth Quarter and Full Year Revenue Full-year 2023 Adjusted EBITDA1 exceeded upper range of prior guidance Cash and cash equivalents, short and long-term restricted cash, and marketable equity securities increased 55% year-over-year to $163.4 million with no debt outstanding Newark, NJ , March 11, 2024 (GLOBE NEWSWIRE) — Genie Energy, Ltd. (NYSE: GNE), a leading retail energy and renewable energy solutions provider, today announced results for the fourth quarter and full year ended December 31, 2023.  Michael Stein, chief executive officer of Genie Energy, commented: “Genie finished a strong year with record fourth quarter and full-year revenue. After reducing our retail customer exposure in 2022, which led to incredible but unsustainable profitability, we returned to customer acquisition mode in 2023, growing both RCEs...

Continue reading

Flow Capital Announces a $2.15 Million Loan to a Fintech Company

TORONTO, March 11, 2024 (GLOBE NEWSWIRE) — Flow Capital Corp. (TSXV:FW) (“Flow Capital” or the “Company”), a leading provider of flexible growth capital and alternative debt solutions, is pleased to announce the successful closure of a C$2.15M senior note to a Canadian fintech SaaS company, with a first tranche advance of C$1.5M. This injection of capital will help the company accelerate its efforts with international expansion, fortify its essential corporate infrastructure, and fuel overall company growth. Flow Capital continues to focus on helping high growth SaaS companies achieve their objectives by providing fast access to growth capital. Flow Capital invites growing technology companies, seeking covenant light founder-friendly growth capital, to apply for funding directly on their website at www.flowcap.com/apply. About...

Continue reading

Lexicon Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Provides Business Update

Commercial launch of INPEFA® (sotagliflozin) continues to progress. with increasing demand across the cardiology community and improving payer access Patient enrollment underway in PROGRESS, a Phase 2b study of LX9211 in Diabetic Peripheral Neuropathic Pain; topline data anticipated Q2 2025 Preparations underway for Phase 3 study of sotagliflozin in Hypertrophic Cardiomyopathy and resubmission of NDA for sotagliflozin in Type 1 Diabetes Recent Successful Capital Raise Supports Company Initiatives for Growth and Expansion Company to Present at the Leerink Partners Global Biopharma Conference Tuesday, March 12th at 3:40 p.m. ET THE WOODLANDS, Texas, March 11, 2024 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today reported financial results for the three months ended December 31, 2023 and provided an update...

Continue reading

Manhattan Bridge Capital, Inc. Reports Results for 2023

GREAT NECK, N.Y., March 11, 2024 (GLOBE NEWSWIRE) — Manhattan Bridge Capital, Inc. (Nasdaq: LOAN) (the “Company”) announced today that net income for the year ended December 31, 2023 was approximately $5,476,000, or $0.48 per share (based on approximately 11.5 million weighted-average outstanding common shares), versus approximately $5,212,000, or $0.45 per share (based on approximately 11.5 million weighted-average outstanding common shares) for the year ended December 31, 2022, an increase of $264,000, or 5.1%. This increase is primarily attributable to an increase in interest income from loans, partially offset by increases in interest expense and in general and administrative expenses. Total revenue for the year ended December 31, 2023 was approximately $9,796,000, compared to approximately $8,571,000 for the year ended December...

Continue reading

Fortrea Reports Fourth Quarter and Full-Year 2023 Results; Issues Full-Year 2024 Guidance

For the three months and full year ended December 31, 2023:Revenues of $775.4 million for the fourth quarter, $3,109.0 million for the full year GAAP net loss of $(36.0) million for the fourth quarter, $(3.4) million for the full year Adjusted EBITDA of $67.2 million for the fourth quarter, $267.3 million for the full year Fourth-quarter book-to-bill ratio of 1.30xDURHAM, N.C., March 11, 2024 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today reported financial results for the fourth quarter and full year ended December 31, 2023. “Fortrea successfully navigated the second half 2023 transforming a “division of a division” into a leader in clinical development,” said Tom Pike, chairman and CEO of Fortrea. “Customers and employees have responded favorably...

Continue reading

Ceco Environmental to Participate in the 36th Annual Roth Conference on March 18

DALLAS, March 11, 2024 (GLOBE NEWSWIRE) — CECO Environmental Corp. (Nasdaq: CECO), a leading environmentally focused, diversified industrial company whose solutions protect people, the environment and industrial equipment, today announced that Todd Gleason, Chief Executive Officer, and Peter Johansson, Chief Financial and Strategy Officer, will participate in the 36th Annual ROTH Conference and host investor meetings throughout the day on Monday, March 18, 2024, at Dana Point, CA. The presentation will be available in the Events and Presentations section of CECO’s Investor Relations website at https://investors.cecoenviro.com/news-events/events ABOUT CECO ENVIRONMENTALCECO Environmental is a leading environmentally focused, diversified industrial company, serving a broad landscape of industrial air, industrial water, and energy...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.